Femtobiomed Inc. (XKON:327610)

South Korea flag South Korea · Delayed Price · Currency is KRW
744.00
+58.00 (8.45%)
At close: Mar 5, 2026
Market Cap6.82B -85.0%
Revenue (ttm)389.96M -1.4%
Net Income-1.21B
EPS-876.00
Shares Out8.54M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,403
Average Volume27,194
Open584.00
Previous Close686.00
Day's Range584.00 - 750.00
52-Week Range518.00 - 6,200.00
Beta0.23
RSI22.52
Earnings Daten/a

About Femtobiomed

Femtobiomed Inc. engages in the development, manufacturing, and wholesale of medical devices and medical supplies in Korea. The company offers CELLSHOT, a versatile platform for small- to medium-scale cell processing; and CellShot suite that integrates hardware, consumables, protective buffers, and digital workflows into a single non-viral cell engineering platform. It also provides SmartDrop, an free-surface analysis platform. The company was founded in 2011 and is based in Seongnam-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2011
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 327610
Full Company Profile

Financial Performance

Financial Statements